A UCLA study identified a chemical compound that may improve lung health, potentially suggesting new approaches to preventing and treating lung diseases. According to the study published Tuesday in Cell Reports, the UCLA team discovered a compound now named Wnt Inhibitor Compound 1, or WIC1, that successfully improved the health of isolated cancerous human and mouse airway cells. Read more...
Photo: Lung cancer tissue (right) has a larger number of basal stem cells compared to normal airway tissue (left). The prevalence of activated beta-catenin (red) in the lung cancer cell can be targeted by Wnt Inhibitor Compound 1, a compound identified by UCLA researchers that successfully improved the health of isolated cancerous human and mouse cells. (Courtesy of UCLA Broad Stem Cell Research Center/Cell Reports)






